Class information for:
Level 1: CYFRA 21 1//PROGRP//CYTOKERATIN 19 FRAGMENT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
9938 1105 28.8 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
608 3       CIRCULATING TUMOR CELLS//CEA//CYFRA 21 1 14209
1581 2             CYFRA 21 1//CEA//CARCINOEMBRYONIC ANTIGEN 7240
9938 1                   CYFRA 21 1//PROGRP//CYTOKERATIN 19 FRAGMENT 1105

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CYFRA 21 1 authKW 3389819 17% 66% 186
2 PROGRP authKW 382098 2% 63% 22
3 CYTOKERATIN 19 FRAGMENT authKW 321767 2% 61% 19
4 PRO GASTRIN RELEASING PEPTIDE authKW 302264 2% 58% 19
5 TUMOR MARKER authKW 234625 15% 5% 171
6 NSE authKW 213704 4% 18% 43
7 NEURON SPECIFIC ENOLASE authKW 210775 6% 11% 70
8 CYFRA authKW 150439 1% 78% 7
9 CYTOKERATIN 19 FRAGMENT ANTIGEN 21 1 authKW 138161 0% 100% 5
10 CEA authKW 125643 6% 7% 69

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 10570 50% 0% 558
2 Respiratory System 2706 13% 0% 147
3 Medical Laboratory Technology 1643 7% 0% 73
4 Otorhinolaryngology 216 3% 0% 37
5 Pathology 195 4% 0% 49
6 Medicine, Research & Experimental 83 4% 0% 49
7 Medicine, General & Internal 74 6% 0% 61
8 Critical Care Medicine 47 2% 0% 18
9 Biotechnology & Applied Microbiology 39 4% 0% 45
10 Surgery 27 5% 0% 56

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CUNEO LUNG CANC STUDY GRP 62795 0% 45% 5
2 PRIMARY REFERENCE CLIN PLICAT LUNG TUMOUR M 55264 0% 100% 2
3 ONCOBIOL UNIT 41445 0% 50% 3
4 BEIJNG CHEST HOSP 36842 0% 67% 2
5 POLIKLIN ARBEITS SOZIALMED 31959 1% 13% 9
6 IMMUNOL TUMOR DIAG 31476 1% 16% 7
7 AFFILIATTED NANJING HOSP 27632 0% 100% 1
8 AIRE HOSP 27632 0% 100% 1
9 ALTHAIA XARXA ASSISTENCIAL DE MAN A 27632 0% 100% 1
10 ARBEITSBEREICH PNEUMOL ONKOL CCM 27632 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF TUMOR MARKER ONCOLOGY 53578 2% 11% 18
2 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 12269 2% 2% 20
3 ANTICANCER RESEARCH 8075 7% 0% 75
4 CANCER BIOMARKERS 7580 1% 2% 13
5 LUNG CANCER 7174 3% 1% 34
6 TUMOR BIOLOGY 5783 3% 1% 36
7 TUMORDIAGNOSTIK & THERAPIE 5097 1% 2% 12
8 JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES 3980 1% 2% 7
9 REVUE DES MALADIES RESPIRATOIRES 3915 2% 1% 23
10 NEOPLASMA 2861 2% 1% 18

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CYFRA 21 1 3389819 17% 66% 186 Search CYFRA+21+1 Search CYFRA+21+1
2 PROGRP 382098 2% 63% 22 Search PROGRP Search PROGRP
3 CYTOKERATIN 19 FRAGMENT 321767 2% 61% 19 Search CYTOKERATIN+19+FRAGMENT Search CYTOKERATIN+19+FRAGMENT
4 PRO GASTRIN RELEASING PEPTIDE 302264 2% 58% 19 Search PRO+GASTRIN+RELEASING+PEPTIDE Search PRO+GASTRIN+RELEASING+PEPTIDE
5 TUMOR MARKER 234625 15% 5% 171 Search TUMOR+MARKER Search TUMOR+MARKER
6 NSE 213704 4% 18% 43 Search NSE Search NSE
7 NEURON SPECIFIC ENOLASE 210775 6% 11% 70 Search NEURON+SPECIFIC+ENOLASE Search NEURON+SPECIFIC+ENOLASE
8 CYFRA 150439 1% 78% 7 Search CYFRA Search CYFRA
9 CYTOKERATIN 19 FRAGMENT ANTIGEN 21 1 138161 0% 100% 5 Search CYTOKERATIN+19+FRAGMENT+ANTIGEN+21+1 Search CYTOKERATIN+19+FRAGMENT+ANTIGEN+21+1
10 CEA 125643 6% 7% 69 Search CEA Search CEA

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MOLINA, R , HOLDENRIEDER, S , AUGE, JM , SCHALHORN, A , HATZ, R , STIEBER, P , (2010) DIAGNOSTIC RELEVANCE OF CIRCULATING BIOMARKERS IN PATIENTS WITH LUNG CANCER.CANCER BIOMARKERS. VOL. 6. ISSUE 3-4. P. 163 -178 85 75% 16
2 SCHNEIDER, J , (2006) TUMOR MARKERS IN DETECTION OF LUNG CANCER.ADVANCES IN CLINICAL CHEMISTRY, VOL 42. VOL. 42. ISSUE . P. 1-41 86 69% 81
3 HOLDENRIEDER, S , NAGEL, D , STIEBER, P , (2010) ESTIMATION OF PROGNOSIS BY CIRCULATING BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.CANCER BIOMARKERS. VOL. 6. ISSUE 3-4. P. 179 -190 58 62% 8
4 CHO, WCS , (2007) POTENTIALLY USEFUL BIOMARKERS FOR THE DIAGNOSIS, TREATMENT AND PROGNOSIS OF LUNG CANCER.BIOMEDICINE & PHARMACOTHERAPY. VOL. 61. ISSUE 9. P. 515-519 36 72% 43
5 KARNAK, D , BEDER, S , KAYACAN, O , IBIS, E , OFLAZ, G , (2005) NEURON-SPECIFIC ENOLASE AND LUNG CANCER.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. VOL. 28. ISSUE 6. P. 586-590 31 91% 11
6 GRUNNET, M , SORENSEN, JB , (2012) CARCINOEMBRYONIC ANTIGEN (CEA) AS TUMOR MARKER IN LUNG CANCER.LUNG CANCER. VOL. 76. ISSUE 2. P. 138-143 23 72% 103
7 JORGENSEN, LGM , (1999) NEURON SPECIFIC ENOLASE IN SMALL CELL LUNG CANCER - CLINICAL AND BIOCHEMICAL EVALUATION.DANISH MEDICAL BULLETIN. VOL. 46. ISSUE 1. P. 1 -12 68 48% 3
8 ISGRO, MA , BOTTONI, P , SCATENA, R , (2015) NEURON-SPECIFIC ENOLASE AS A BIOMARKER: BIOCHEMICAL AND CLINICAL ASPECTS.ADVANCES IN CANCER BIOMARKERS: FROM BIOCHEMISTRY TO CLINIC FOR A CRITICAL REVISION. VOL. 867. ISSUE . P. 125 -143 42 43% 8
9 CEDRES, S , NUNEZ, I , LONGO, M , MARTINEZ, P , CHECA, E , TORREJON, D , FELIP, E , (2011) SERUM TUMOR MARKERS CEA, CYFRA21-1, AND CA-125 ARE ASSOCIATED WITH WORSE PROGNOSIS IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC).CLINICAL LUNG CANCER. VOL. 12. ISSUE 3. P. 172 -179 25 76% 55
10 BUCCHERI, G , FERRIGNO, D , (2001) LUNG TUMOR MARKERS OF CYTOKERATIN ORIGIN: AN OVERVIEW.LUNG CANCER. VOL. 34. ISSUE . P. S65 -S69 31 89% 26

Classes with closest relation at Level 1


Rank Class id link
1 19922 SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3
2 19042 ENOLASE//ALPHA ENOLASE//UPPER LIMB BUD
3 18737 SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY//2G3 ESOPHAGEAL MONOCLONAL ANTIBODY
4 11659 CA 15 3//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN//CA 549
5 29102 M65//M30//CYTOKERATIN 18
6 9750 CA 19 9//CA 72 4//CA 242
7 9222 LARGE CELL NEUROENDOCRINE CARCINOMA//TYPICAL CARCINOID//ATYPICAL CARCINOID
8 5873 S100B//NEURON SPECIFIC ENOLASE//S100B PROTEIN
9 24054 PLACENTAL ISOFERRITIN//P43 ISOFERRITIN//PLACENTAL FERRITIN
10 5837 CYTOKERATIN//KERATIN//HAMSTER CHEEK POUCH EPITHELIUM

Go to start page